ResearcherShimane UniversityNo recent work listed

Keizo Takenaga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9127-2965; OpenAlex author ID A5103000882. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model. Co-author DOI 10.1371/journal.pone.0232230 ↗
Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death. Last author DOI 10.1371/journal.pone.0126605 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Miho Akimoto · 2 shared papers, 2015–2020 · strength 0.23
- Paper Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer m… DOI 10.1371/journal.pone.0232230 ↗
- Paper Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Aut… DOI 10.1371/journal.pone.0126605 ↗
Hiroki Nagase · 1 shared paper, 2020 · strength 0.16
- Paper Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer m… DOI 10.1371/journal.pone.0232230 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.